RC
CLBT icon

Roubaix Capital’s Cellebrite CLBT Stock Holding History

Roubaix Capital’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.6M Buy
383,672
+80,457
+27% +$1.06M 2.01% 23
2026
Q1 		$4.18M Buy
303,215
+157,536
+108% +$2.37M 1.95% 29
2025
Q4 		$2.63M Sell
145,679
-41,442
-22% -$744K 1.12% 45
2025
Q3 		$3.47M Buy
187,121
+11,837
+7% +$186K 1.61% 32
2025
Q2 		$2.8M Buy
+175,284
New +$3.12M 1.35% 39

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Roubaix Capital's CLBT Position: Q2 2026 in Review

Roubaix Capital increased its Cellebrite (CLBT) stake by 27% in Q2 2026, buying an estimated $1.06M and bringing the position to 383,672 shares worth $5.6M. The position accounts for 2.01% of the portfolio, ranked #23.

Roubaix Capital first reported a position in CLBT in Q2 2025 and has held it in 5 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Roubaix Capital held 383,672 shares of Cellebrite worth $5.6M as of Q2 2026.
  • Roubaix Capital bought 80,457 Cellebrite shares in Q2 2026, an estimated $1.06M.
  • Cellebrite made up 2.01% of Roubaix Capital's portfolio in Q2 2026, its #23 holding.
  • Roubaix Capital first reported a position in Cellebrite in Q2 2025 and has held it in 5 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Roubaix Capital's 13F filing for Q2 2026, filed 10 Aug 2026.